UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
WASHINGTON,
D.C. 20549
FORM
8-K
CURRENT
REPORT
PURSUANT TO SECTION
13 OR 15(d) OF THE
SECURITIES
EXCHANGE ACT OF 1934
Date
of Report (Date of earliest event reported): June 21, 2013
DYAX
CORP.
(Exact
Name of Registrant as Specified in Charter)
Delaware |
000-24537 |
04-3053198 |
(State or Other Jurisdiction of Incorporation) |
(Commission File Number)
|
(IRS Employer Identification No.)
|
55 Network Drive |
(Address of Principal Executive Offices) (Zip Code) |
(617) 225-2500
(Registrant’s
telephone number, including area code)
Not
Applicable
(Former
name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
⃞ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
⃞ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
⃞ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
⃞ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 1.01. Entry into a Material Definitive Agreement.
On June 21, 2013, Dyax Corp. ("Dyax") and Hollister Stier Laboratories, LLC ("Hollister Stier") entered into an exclusive agreement under which Hollister Stier will perform all fill, finishing, packaging and manufacturing services for Dyax’s lead product KALBITOR® (ecallantide). The Agreement has a five year term, but can be terminated by either party with two years prior written notice. Under the agreement, there are no financial obligations for Dyax unless and until binding orders for finished product are placed by Dyax.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
DYAX CORP. |
||||
|
||||
Dated: |
June 25, 2013 | By: |
/s/ George Migausky |
|
George Migausky |
||||
Executive Vice President and |
||||
Chief Financial Officer |